VERY STRONG MANAGEMENT TEAM WHO HAVE VIAGRA, CARBOPLATIN, CISPLATIN AND PLETHORA AMONGST THEIR DISCOVERIES
Dr Mike Wyllie
Non-Executive Chairman
30 years’ experience, ex-Director at Pfizer involved in the discovery, filing of intellectual property, development, regulatory filing and marketing. Led the Pfizer urology team, with successes including Viagra.
Jonathan Beatson-Hird
Chief Executive Officer
After spending 24 years Investment Banking in New York, founded Sarum Partners, a specialist Oncology consultancy and investment group in 2009 which holds 13.09% of Morvus.
Mrs Judith Phillips
Chief Finance Officer
One of the founders of Morvus, Judith is a Chartered Secretary with experience working in the biotech sector since 1994.
Professor Richard Knox
Chief Scientific Officer
Ex leader of the Molecular Pharmacology team at the Institute of Cancer Research (ICR), London, which developed carboplatin and cisplatin. Richard is a founder of Morvus and an expert on the platinates.
Dr Mike Hudson
CEO, Gordian Pharma
Mike has developed valuable, technology-based businesses in the areas of orphan drugs, cell-based drug screening and radiation oncology following an early career with Unilever and Bristol Myers Squibb. He has a strong track record in growing SMEs in the biotechnology sector.